BAYER HLTHCARE FDA Approval NDA 020860

NDA 020860

BAYER HLTHCARE

FDA Drug Application

Application #020860

Documents

Letter1998-07-14
Review1999-01-21

Application Sponsors

NDA 020860BAYER HLTHCARE

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL-210.02MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1LEVLITEETHINYL ESTRADIOL; LEVONORGESTREL
002TABLET;ORAL-280.02MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1LEVLITEETHINYL ESTRADIOL; LEVONORGESTREL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1998-07-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2001-12-17STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20860
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.